The Importance of Testing PET-Directed Therapy in Patients with Hodgkin Lymphoma
- James O. Armitage
- … show all 1 hide
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
Measuring the rapidity of response by PET scan and changing the treatment regimen in slow responders may lead to an improved outcome. Ongoing studies addressing this possibility have the potential to answer this question and need to be supported.
- Peters MV, Middlemiss KC. A study of Hodgkin’s disease treated by irradiation. Am J Roentgenol Radium Ther Nucl Med. 1958;79(1):114–21.
- Kaplan HS. The radical radiotherapy of regionally localized Hodgkin’s disease. Radiology. 1962;78:553–61.
- DeVita Jr VT, Serpick AA, Carbone PP. Combination chemotherapy in the treatment of advanced Hodgkin’s disease. Ann Intern Med. 1970;73(6):881–95.
- Armitage JO. Early-stage Hodgkin’s lymphoma. N Engl J Med. 2010;363(7):653–62. CrossRef
- Sher DJ, Mauch PM, Van Den Abbeele A, LaCasce AS, Czerminski J, Ng AK. Prognostic significance of mid- and post-ABVD PET imaging in Hodgkin’s lymphoma: the importance of involved-field radiotherapy. Ann Oncol. 2009;20(11):1848–53. CrossRef
- Barnes J, LaCasce A, Toomey C, et al. Early interim FDG-PET scan predicts outcome in non-bulky limited stage Hodgkin lymphoma, but may not guide use of consolidative radiotherapy [abstract]. Blood. 2008;112:518.
- The Importance of Testing PET-Directed Therapy in Patients with Hodgkin Lymphoma
Current Hematologic Malignancy Reports
Volume 6, Issue 3 , pp 155-156
- Cover Date
- Print ISSN
- Online ISSN
- Current Science Inc.
- Additional Links
- Industry Sectors
- Author Affiliations
- 1. The Joe Shapiro Professor of Medicine, Department of Internal Medicine, University of Nebraska Medical Center, 987680 Nebraska Medical Center, Omaha, NE, 68198-7680, USA